Janneke S. Hoogstad‐van Evert

ORCID: 0000-0001-9838-0977 · 5 papers in corpus
article 2025
EXPLORING THE IMPACT OF AN ANTI-INFLAMMATORY DIET ON PAIN AND INFLAMMATORY MARKERS IN WOMEN WITH ENDOMETRIOSIS: A FEASIBILITY STUDY
·doi:10.1016/j.jri.2024.104351
2025
Menstrual Effluent Derived Immune Cell Composition Is Distinct in Women Using Contraceptives: A Pilot Study.
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.70145

ProblemMenstrual effluent (ME) is widely used to study immune-related reproductive disorders. However, women using contraceptives are often excluded from such studies due to limited knowledge of their impact on the endometrial immune cell c…

review 2022
The Promises of Natural Killer Cell Therapy in Endometriosis
International journal of molecular sciences ·doi:10.3390/ijms23105539

Endometriosis is a gynaecological disease defined by the growth of endometrium-like tissue outside the uterus. The disease is present in approximately 5-10% of women of reproductive age and causes pelvic pain and infertility. The pathophysi…

2020
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer.
Oncoimmunology ·doi:10.1080/2162402x.2020.1843247

Advanced ovarian cancer (OC) patients have a poor 5-year survival of only 28%, emphasizing the medical need for improved therapies. Adjuvant immunotherapy could be an attractive approach since OC is an immunogenic disease and the presence o…

2018
Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients.
Oncotarget ·doi:10.18632/oncotarget.26199

The demonstration that ovarian carcinoma (OC) is an immunogenic disease, opens opportunities to explore immunotherapeutic interventions to improve clinical outcome. In this regard, NK cell based immunotherapy could be promising as it has be…